At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
NIMBUS Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Study of Patients to Evaluate NIMBUS Revascularization Effectiveness With Challenging Occlusions
In Brief
An observational study evaluating NIMBUS Device for Cerebral Stroke. Completed, enrolled 54 participants across 2 sites in 2 countries.
Detailed Summary
A post-market study evaluating the NIMBUS Device in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Stroke
CountriesGermany, Sweden
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedApr 2019
Enrollment StartOct 2019
Primary CompletionFeb 2022
Study CompletionApr 2022
TodayJul 2026
First PostedApr 2, 2019
Enrollment StartOct 30, 2019
Primary CompletionFeb 15, 2022
Study CompletionApr 8, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.3 years ago
Interventions
NIMBUS Devicedevice
NIMBUS Geometric Clot Extractor